Concordance Between Electronic Health Record Data and Medicare Part D Claims Data for Oral Anticancer Drug Use

Authors

Manvi Sharma, University of MississippiFollow
Michael L. Johnson, University of Houston
Hui Zhao, The University of Texas MD Anderson Cancer Center
Sharon H. Giordano, The University of Texas MD Anderson Cancer Center
Holly M. Holmes, University of Texas Health Science Center at Houston

Document Type

Article

Publication Date

4-30-2020

Abstract

Real-world evidence from electronic health records (EHRs) and claims data are being evaluated for use in regulatory decision-making.^1,2 The objective of our study was to determine the concordance between EHR and Medicare Part D (MPD) claims data for the receipt of oral anticancer agents, a rapidly growing treatment option for cancer.

Relational Format

journal article

Comments

The Article Processing Charge (APC) for this article was partially funded by the UM Libraries Open Access Fund.

Recommended Citation

Sharma M, Johnson ML, Zhao H, Giordano SH, Holmes HM. Concordance Between Electronic Health Record Data and Medicare Part D Claims Data for Oral Anticancer Drug Use. JAMA Netw Open. 2020;3(4):e203821. doi:10.1001/jamanetworkopen.2020.3821